GSK Recalls Panadol Advance Bottles for Non-Child-Resistant Packaging
GSK is recalling Panadol Advance pain relievers sold in Puerto Rico because the bottles do not meet child-resistant closure requirements.
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall addresses a packaging compliance issue (failure to meet child-resistant closure requirements) with no reported injuries, fitting the criteria for moderate severity involving low-risk contamination or voluntary precautionary measures.
Plain-English summary
GlaxoSmithKline (GSK) is recalling approximately 10,600 bottles of Panadol Advance 100 count caplets. The recall is due to the packaging failing to meet the child-resistant closure requirements mandated by the Poison Prevention Packaging Act. The affected products contain acetaminophen, which requires child-resistant packaging.
The recalled medicine was sold in white containers with a blue label inside a blue box. The products were sold exclusively in Puerto Rico at drug, grocery, and mass merchandise stores from November 2012 through February 2014 for about $10. The specific lot numbers included in the recall are 14241 (expiration 02/2015), 14002 (expiration 10/2014), 13881 (expiration 09/2014), and 13801 (expiration 09/2014).
No injuries have been reported. Consumers should immediately place the product out of a child's sight and reach. They should contact GSK toll-free at (888) 912-8455 from 9 a.m. to 5 p.m. ET Monday through Friday, or visit www.us.gsk.com to request a refund.
The recalled product
- Product
- Panadol Advance® 100 count caplets
- Manufacturer
- GlaxoSmithKline (GSK), of Moon Township, Penn.
- Category
- Drug — Pain Relievers
- Affected units
- 10,600
Distribution
Distributed nationwide across the United States.
Related recalls
Same hazard · packaging defect
See all →- HighEmbosphere Microspheres Recalled Due to Packaging Sterility Concerns
FDA (Devices) · 2026-10-07
- ModerateAmneal Recalls Estradiol Gel Packets Due to Empty or Partially Full Containers
FDA (Drugs) · 2026-10-07
- HighCardinal Health Recalls Presource Convenience Kits Due to Seal Defects
FDA (Devices) · 2026-09-30
- ModerateAVID Medical Recalls Halyard IV Start Kits Due to Packaging Seal Issues
FDA (Devices) · 2026-09-30
- HighCardinal Health Recalls Presource Convenience Kits Due to Potential Seal Defects
FDA (Devices) · 2026-09-30
Similar recalls
- LowGlaxoSmithKline Recalls Panadol Acetaminophen Extra Strength for Dissolution Failures
FDA (Drugs) · 2015-08-12
- High
- ModerateGSK Recalls Prevacid 24HR Capsules Due to Manufacturing Deviations
FDA (Drugs) · 2018-10-17
- High
- High
- HighFDA Recalls Pravastatin Sodium Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2023-03-08